skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Amelioration of Alzheimer’s disease pathology and cognitive deficits by immunomodulatory agents in animal models of Alzheimer’s disease

Journal Article · · Neural Regeneration Research
 [1];  [2]
  1. Univ. of California, Merced, Merced, CA (United States). Dept. of Molecular & Cellular Biology; St. Georges Univ. School of Medicine, Grenada. Dept. of Medicine; Los Alamos National Lab (LANL), Los Alamos, NM (United States). Dept. of Physics and Engineering
  2. Univ. of Otago, Dunedin, New Zealand. Dept. of Anatomy

The most common age-related neurodegenerative disease is Alzheimer’s disease (AD) characterized by aggregated amyloid-β (Aβ) peptides in extracellular plaques and aggregated hyperphosphorylated tau protein in intraneuronal neurofibrillary tangles, together with loss of cholinergic neurons, synaptic alterations, and chronic inflammation within the brain. These lead to progressive impairment of cognitive function. There is evidence of innate immune activation in AD with microgliosis. Classically-activated microglia (M1 state) secrete inflammatory and neurotoxic mediators, and peripheral immune cells are recruited to inflammation sites in the brain. The few drugs approved by the US FDA for the treatment of AD improve symptoms but do not change the course of disease progression and may cause some undesirable effects. Translation of active and passive immunotherapy targeting Aβ in AD animal model trials had limited success in clinical trials. Treatment with immunomodulatory/anti-inflammatory agents early in the disease process, while not preventive, is able to inhibit the inflammatory consequences of both Aβ and tau aggregation. The studies described in this review have identified several agents with immunomodulatory properties that alleviated AD pathology and cognitive impairment in animal models of AD. The majority of the animal studies reviewed had used transgenic models of early-onset AD. More effort needs to be given to create models of late-onset AD. The effects of a combinational therapy involving two or more of the tested pharmaceutical agents, or one of these agents given in conjunction with one of the cell-based therapies, in an aged animal model of AD would warrant investigation.

Research Organization:
Los Alamos National Lab (LANL), Los Alamos, NM (United States)
Sponsoring Organization:
USDOE
Grant/Contract Number:
AC52-06NA25396
OSTI ID:
1628700
Journal Information:
Neural Regeneration Research, Vol. 14, Issue 7; ISSN 1673-5374
Publisher:
Chinese Association of Rehabilitation Medicine (CARM)Copyright Statement
Country of Publication:
United States
Language:
English

References (112)

Novel Regimens and Delivery Systems in the Pharmacological Treatment of Alzheimerʼs Disease journal January 2009
Molecular Basis of Familial and Sporadic Alzheimer's Disease journal July 2016
Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes journal January 1998
Nutrition and the Risk of Alzheimer's Disease journal January 2013
Alzheimer's disease journal February 2009
Low-dose memantine attenuated methadone dose in opioid-dependent patients: a 12-week double-blind randomized controlled trial journal May 2015
Multitarget Therapeutic Effect of Fasudil in APP/PS1transgenic Mice journal February 2017
Commentary to the recently published review “Drug pipeline in neurodegeneration based on transgenic mice models of Alzheimer's disease” by Li, Evrahimi and Schluesener. Ageing Res. Rev. 2013 Jan;12(1):116–40 journal September 2013
Potential Immunotargets for Alzheimer's Disease Treatment Strategies journal December 2012
Antioxidant Activity of Quercetin and Its Glucosides from Propolis: A Theoretical Study journal August 2017
Protective effect of fasudil, a Rho-kinase inhibitor, on chemokine expression, leukocyte recruitment, and hepatocellular apoptosis in septic liver injury journal May 2006
APOE3, but Not APOE4, Bone Marrow Transplantation Mitigates Behavioral and Pathological Changes in a Mouse Model of Alzheimer Disease journal September 2013
Long-term immunomodulatory effect of amniotic stem cells in an Alzheimer's disease model journal October 2013
Interleukin-1 receptor antagonist: an early immunomodulatory cytokine induced by porcine reproductive and respiratory syndrome virus journal January 2017
The effects of immunomodulation by macrophage subsets on osteogenesis in vitro journal January 2016
Human umbilical cord blood-derived mesenchymal stem cells improve neuropathology and cognitive impairment in an Alzheimer's disease mouse model through modulation of neuroinflammation journal March 2012
Immunomodulatory effect of an isolated fraction from Tinospora crispa on intracellular expression of INF-γ, IL-6 and IL-8 journal June 2014
Intraneuronal APP and extracellular Aβ independently cause dendritic spine pathology in transgenic mouse models of Alzheimer’s disease journal April 2015
PPARγ-dependent anti-tumor and immunomodulatory actions of pioglitazone journal November 2014
Immunomodulation by memantine in therapy of Alzheimer's disease is mediated through inhibition of Kv1.3 channels and T cell responsiveness journal July 2016
The amyloid cascade-inflammatory hypothesis of Alzheimer disease: implications for therapy journal September 2013
Intraneuronal beta-Amyloid Aggregates, Neurodegeneration, and Neuron Loss in Transgenic Mice with Five Familial Alzheimer's Disease Mutations: Potential Factors in Amyloid Plaque Formation journal October 2006
Rho Kinase Inhibitor Fasudil Protects againstβ-Amyloid-Induced Hippocampal Neurodegeneration in Rats journal May 2013
Evaluation of the immunomodulatory effect of melatonin on the T-cell response in peripheral blood from systemic lupus erythematosus patients journal February 2015
Amniotic membrane-derived stem cells: immunomodulatory properties and potential clinical application journal March 2014
Immunomodulation with eicosapentaenoic acid supports the treatment of autoimmune small-vessel vasculitis journal September 2014
Antinociceptive and anti-inflammatory effects of choline in a mouse model of postoperative pain journal August 2010
Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: A role for A2A receptors journal November 2013
Modulation of TNF Release by Choline Requires α7 Subunit Nicotinic Acetylcholine Receptor-Mediated Signaling journal June 2008
Monitoring Blood-Brain Barrier Integrity Following Amyloid-β Immunotherapy Using Gadolinium-Enhanced MRI in a PDAPP Mouse Model journal September 2016
Early neurovascular dysfunction in a transgenic rat model of Alzheimer’s disease journal April 2017
Neuroinflammation in Alzheimer's disease journal April 2015
Rosiglitazone Modulates the Innate Immune Response toPlasmodium falciparumInfection and Improves Outcome in Experimental Cerebral Malaria journal May 2009
Effects of curcumin on short-term spatial and recognition memory, adult neurogenesis and neuroinflammation in a streptozotocin-induced rat model of dementia of Alzheimer’s type journal September 2017
Neuroprotective effects of CD4+CD25+Foxp3+ regulatory T cells in a 3xTg-AD Alzheimer's disease model journal October 2016
Toward more predictive genetic mouse models of Alzheimer's disease journal April 2016
Mapping the effects of drugs on the immune system journal January 2016
Pharmacokinetics, safety and immunomodulatory effects of human recombinant interleukin-1 receptor antagonist in healthy humans journal September 1992
A noninflammatory immune response in aged DNA Aβ42-immunized mice supports its safety for possible use as immunotherapy in AD patients journal March 2015
Preventing cognitive decline in preclinical Alzheimer's disease journal February 2014
Immunomodulation of microglia by docosahexaenoic acid and eicosapentaenoic acid journal February 2012
Neuroinflammation and M2 microglia: the good, the bad, and the inflamed journal June 2014
In vitro induction of regulatory T cells by anti-CD3 antibody in humans journal February 2008
Immunomodulatory effects of eicosapentaenoic acid through induction of regulatory T cells journal March 2011
Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease journal December 2003
The molecular pathology of Alzheimer's disease journal April 1991
Effects and mechanisms of actions of phytochemicals on Alzheimer rsquo s disease neuropathology journal January 2018
Melatonin and Immunomodulation: Connections and Potential Clinical Applications journal January 2006
M2 Macrophage Transplantation Ameliorates Cognitive Dysfunction in Amyloid-β-Treated Rats Through Regulation of Microglial Polarization journal May 2016
Curcumin Ameliorates Neuroinflammation, Neurodegeneration, and Memory Deficits in p25 Transgenic Mouse Model that Bears Hallmarks of Alzheimer’s Disease journal November 2017
Grading score system: A method for evaluation of the degree of senescence in Senescence Accelerated Mouse (SAM) journal July 1984
The behavioral, pathological and therapeutic features of the senescence-accelerated mouse prone 8 strain as an Alzheimer's disease animal model journal January 2014
Adoptive Transfer of Immunomodulatory M2 Macrophages Prevents Type 1 Diabetes in NOD Mice journal October 2012
Anti-Diabetes Drug Pioglitazone Ameliorates Synaptic Defects in AD Transgenic Mice by Inhibiting Cyclin-Dependent Kinase5 Activity journal April 2015
A Rat Model of Alzheimer’s Disease Based on Abeta42 and Pro-oxidative Substances Exhibits Cognitive Deficit and Alterations in Glutamatergic and Cholinergic Neurotransmitter Systems journal April 2016
Th1 Polarization of T Cells Injected into the Cerebrospinal Fluid Induces Brain Immunosurveillance journal January 2014
Quercetin reverses experimental cirrhosis by immunomodulation of the proinflammatory and profibrotic processes journal August 2017
Neuritic plaque evolution in Alzheimer's disease is accompanied by transition of activated microglia from primed to enlarged to phagocytic forms journal July 1997
Modeling Alzheimer’s disease in transgenic rats journal January 2013
Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells journal June 2013
Neuroprotective and cognitive enhancing effects of a multi-targeted food intervention in an animal model of neurodegeneration and depression journal April 2014
The Cholinergic Anti-inflammatory Pathway: A Missing Link in Neuroimmunomodulation journal May 2003
Wild gut microbiota protects from disease journal December 2017
Chronological Age Impacts Immunotherapy and Monocyte Uptake Independent of Amyloid Load journal December 2011
Role of NMDA Receptor-Mediated Glutamatergic Signaling in Chronic and Acute Neuropathologies journal January 2016
Coordination properties of a metal chelator clioquinol to Zn2+ studied by static DFT and ab initio molecular dynamics journal January 2015
Vaccine-induced Aβ-specific CD8+ T cells do not trigger autoimmune neuroinflammation in a murine model of Alzheimer’s disease journal May 2015
Interactions between APP secretases and inflammatory mediators journal January 2008
Quercetin, Inflammation and Immunity journal March 2016
The flavonoid quercetin ameliorates Alzheimer's disease pathology and protects cognitive and emotional function in aged triple transgenic Alzheimer's disease model mice journal June 2015
Long-term use of thiazolidinediones and the associated risk of pneumonia or lower respiratory tract infection: systematic review and meta-analysis journal February 2011
Natural Phytochemicals in the Treatment and Prevention of Dementia: An Overview journal April 2016
Memantine partly rescues behavioral and cognitive deficits in an animal model of neurodegeneration journal April 2012
Role of genes linked to sporadic Alzheimer’s disease risk in the production of β-amyloid peptides journal September 2012
Peripheral immune system in aging and Alzheimer’s disease journal October 2018
Interleukin-1 as a Phenotypic Immunomodulator in Keratinizing Squamous Metaplasia of the Ocular Surface in Sjögren's Syndrome journal September 2010
Long-Term Cannabidiol Treatment Prevents the Development of Social Recognition Memory Deficits in Alzheimer's Disease Transgenic Mice journal October 2014
Neurobehavioral and Neuropsychiatric Symptoms in Alzheimer'S Disease journal November 2000
Memantine, an Antagonist of the NMDA Glutamate Receptor, Affects Cell Proliferation, Differentiation and the Intracellular Cycle and Induces Apoptosis in Trypanosoma cruzi journal February 2014
Targeting sTNF/TNFR1 Signaling as a New Therapeutic Strategy journal March 2015
Mechanisms Underlying Inflammation in Neurodegeneration journal March 2010
The age factor in Alzheimer’s disease journal October 2015
Alzheimer's disease: the amyloid cascade hypothesis journal April 1992
Midlife Fruit and Vegetable Consumption and Risk of Dementia in Later Life in Swedish Twins journal May 2010
PPAR-γ agonists inhibit production of monocyte inflammatory cytokines journal January 1998
Immunomodulation by Dietary n3-Polyunsaturated Fatty Acids (PUFA) In Vitro journal February 2006
Drug pipeline in neurodegeneration based on transgenic mice models of Alzheimer's disease journal January 2013
Tumor Necrosis Factor-α, Interleukin-1β, and Interferon-γ Stimulate γ-Secretase-mediated Cleavage of Amyloid Precursor Protein through a JNK-dependent MAPK Pathway journal November 2004
Fasudil mediates cell therapy of EAE by immunomodulating encephalomyelitic T cells and macrophages journal November 2014
Rosiglitazone, a peroxisome proliferator-activated receptor-γ agonist, attenuates acrolein-induced airway mucus hypersecretion in rats journal June 2009
Peripheral administration of the soluble TNF inhibitor XPro1595 modifies brain immune cell profiles, decreases beta-amyloid plaque load, and rescues impaired long-term potentiation in 5xFAD mice journal June 2017
The Immunomodulatory Properties of Amniotic Cells journal January 2018
Microglia and Inflammation in Alzheimers Disease journal April 2010
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease journal April 2011
Stem/progenitor cells from bone marrow decrease neuronal death in global ischemia by modulation of inflammatory/immune responses journal September 2008
Choline Suppresses Inflammatory Responses journal June 2006
Interleukin-1β mediated amyloid plaque clearance is independent of CCR2 signaling in the APP/PS1 mouse model of Alzheimer's disease journal September 2014
Wild Mouse Gut Microbiota Promotes Host Fitness and Improves Disease Resistance journal November 2017
Selective Chemokine Receptor Usage by Central Nervous System Myeloid Cells in CCR2-Red Fluorescent Protein Knock-In Mice journal October 2010
Immunomodulatory properties and therapeutic application of mesenchymal stem cells journal February 2011
Role of anti-CD3 in modulation of Th1-type immune response in Shigella dysenteriae infection journal November 2004
Increased Phospholipase A2 Activity and Inflammatory Response But Decreased Nerve Growth Factor Expression in the Olfactory Bulbectomized Rat Model of Depression: Effects of Chronic Ethyl-Eicosapentaenoate Treatment journal January 2009
The Intersection of Amyloid Beta and Tau at Synapses in Alzheimer’s Disease journal May 2014
Immunomodulatory and antitumor activity of Piper longum Linn. and piperine journal February 2004
LW-AFC, A New Formula Derived from Liuwei Dihuang Decoction, Ameliorates Cognitive Deterioration and Modulates Neuroendocrine-Immune System in SAMP8 Mouse journal January 2017
Glial activation: a driving force for pathological pain journal August 2001
Immunotherapy for Alzheimer's disease journal April 2014
Olfactory bulbectomy as a putative model for Alzheimer’: The protective role of essential fatty acids journal January 2014
Insulin sensitizers improve learning and attenuate tau hyperphosphorylation and neuroinflammation in 3xTg-AD mice journal August 2014
Oral administration of cannabis with lipids leads to high levels of cannabinoids in the intestinal lymphatic system and prominent immunomodulation journal November 2017
Efficacy and Toxicity of Clioquinol Treatment and A-beta42 Inoculation in the APP/PSI Mouse Model of Alzheimer’s Disease journal May 2013
Neuroinflammation impairs adaptive structural plasticity of dendritic spines in a preclinical model of Alzheimer’s disease journal January 2016

Cited By (4)

Genetic Background Influences the Propagation of Tau Pathology in Transgenic Rodent Models of Tauopathy journal December 2019
The Role of Macrophage Migration Inhibitory Factor in Alzheimer′s Disease: Conventionally Pathogenetic or Unconventionally Protective? journal January 2020
Single Administration of the T-Type Calcium Channel Enhancer SAK3 Reduces Oxidative Stress and Improves Cognition in Olfactory Bulbectomized Mice journal January 2021
Early active immunization with Aβ3–10-KLH vaccine reduces tau phosphorylation in the hippocampus and protects cognition of mice journal January 2020